Li Su
About
Li Su is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Li Su has authored 248 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 60 papers in Oncology and 57 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Li Su's work include RNA modifications and cancer (25 papers), Esophageal Cancer Research and Treatment (16 papers) and Lung Cancer Treatments and Mutations (16 papers). Li Su is often cited by papers focused on RNA modifications and cancer (25 papers), Esophageal Cancer Research and Treatment (16 papers) and Lung Cancer Treatments and Mutations (16 papers). Li Su collaborates with scholars based in China, United States and Canada. Li Su's co-authors include David C. Christiani, Geoffrey Liu, Chia‐Ling Wu, Claude Gorka, G H Enders, Matthew Meyerson, Ed Harlow, Li‐Huei Tsai, Kofi Asomaning and Rihong Zhai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
In The Last Decade
Li Su
239 papers receiving 6.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Li Su China | 41 | 2.4k | 1.5k | 1.1k | 999 | 743 | 248 | 6.3k | ||
| Eun Young Kim South Korea | 47 | 2.9k 1.2× | 1.1k 0.7× | 1.4k 1.3× | 530 0.5× | 1.0k 1.4× | 357 | 8.3k | ||
| Stig E. Bojesen Denmark | 50 | 2.4k 1.0× | 1.8k 1.1× | 1.4k 1.3× | 1.7k 1.7× | 840 1.1× | 172 | 8.3k | ||
| Dirk Reinhardt Germany | 60 | 4.3k 1.8× | 1.8k 1.2× | 1.2k 1.1× | 1.3k 1.3× | 616 0.8× | 452 | 11.6k | ||
| Gang Xu China | 39 | 2.0k 0.8× | 1.5k 1.0× | 940 0.9× | 552 0.6× | 697 0.9× | 218 | 8.0k | ||
| Hongwei Wang China | 44 | 3.1k 1.3× | 1.2k 0.7× | 656 0.6× | 620 0.6× | 712 1.0× | 288 | 7.4k | ||
| Rebecca Troisi United States | 44 | 2.0k 0.9× | 2.0k 1.3× | 1.6k 1.5× | 1.2k 1.2× | 395 0.5× | 152 | 8.3k | ||
| Anne Zeleniuch‐Jacquotte United States | 52 | 2.1k 0.9× | 3.3k 2.1× | 609 0.6× | 1.3k 1.3× | 485 0.7× | 168 | 8.9k | ||
| Mary J. Emond United States | 44 | 4.1k 1.7× | 944 0.6× | 1.4k 1.3× | 1.1k 1.1× | 1.1k 1.5× | 117 | 10.0k | ||
| Lei Wang China | 42 | 3.3k 1.4× | 658 0.4× | 549 0.5× | 1.1k 1.1× | 589 0.8× | 310 | 6.5k | ||
| Bo Zhang China | 40 | 2.6k 1.1× | 1.6k 1.1× | 939 0.9× | 1.1k 1.1× | 672 0.9× | 252 | 6.8k |
Countries citing papers authored by Li Su
Since
Specialization
Citations
This map shows the geographic impact of Li Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Su more than expected).
Fields of papers citing papers by Li Su
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Li Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Su. The network helps show where Li Su may publish in the future.
Co-authorship network of co-authors of Li Su
This figure shows the co-authorship network connecting the top 25 collaborators of Li Su. A scholar is included among the top collaborators of Li Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Su. Li Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ke, Liyuan, et al.. (2024). Efficacy and safety of VEGF/VEGFR inhibitors for platinum-resistant ovarian cancer: a systematic review and meta-analysis of randomized controlled trials. BMC Women s Health. 24(1). 34–34.
2.
Yuan, Minjie, Haimin Xu, Dongdong Shi, et al.. (2024). Tele-rehabilitation for Type II diabetics with heart failure with preserved ejection fraction. Frontiers in Endocrinology. 15. 1433297–1433297.
3.
Liu, Guyue, Li Su, & Mingjian Lang. (2023). A systematic review and meta-analysis of sex differences in clinical outcomes of hypertrophic cardiomyopathy. Frontiers in Cardiovascular Medicine. 10. 1252266–1252266.
4.
Liu, Wei, Yuling Li, Li Su, et al.. (2023). Identification of biomarkers and immune infiltration in acute myocardial infarction and heart failure by integrated analysis. Bioscience Reports. 43(7).
5.
Zhou, You, Zhangwei Chen, Ao Chen, et al.. (2021). Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention. European Heart Journal - Quality of Care and Clinical Outcomes. 8(8). 871–880.
6.
Aredo, Jacqueline V., Natasha Purington, Li Su, et al.. (2021). Metabolomic profiling for second primary lung cancer: A pilot case-control study. Lung Cancer. 155. 61–67.
7.
Quick, Corbin, Marta Guasch‐Ferré, Zhu Zhuo, et al.. (2021). The Association Between Inflammatory and Oxidative Stress Biomarkers and Plasma Metabolites in a Longitudinal Study of Healthy Male Welders. Journal of Inflammation Research. Volume 14. 2825–2839.
8.
Deng, Wei, Hongliang Liu, Sheng Luo, et al.. (2020). APOBGenotypes andCDH13Haplotypes in the Cholesterol-Related Pathway Genes Predict Non–Small Cell Lung Cancer Survival. Cancer Epidemiology Biomarkers & Prevention. 29(6). 1204–1213.
9.
Zhao, Yu, Dongfang Tang, Sen Yang, et al.. (2020). Novel Variants of ELP2 and PIAS1 in the Interferon Gamma Signaling Pathway Are Associated with Non–Small Cell Lung Cancer Survival. Cancer Epidemiology Biomarkers & Prevention. 29(8). 1679–1688.
10.
Zhang, Zhonghan, Yang Zhang, Fan Luo, et al.. (2020). Dual blockade of EGFR and VEGFR pathways: Results from a pilot study evaluating apatinib plus gefitinib as a first‐line treatment for advanced EGFR‐mutant non‐small cell lung cancer. SHILAP Revista de lepidopterología. 10(2). e33–e33.
11.
Xu, Yanping, Zhiyu Ling, Weijie Chen, et al.. (2019). Radiofrequency catheter ablation for paroxysmal atrial fibrillation: outcomes during a 3-year follow-up period. Journal of International Medical Research. 47(4). 1636–1648.
12.
Pang, Bo, Nan Wu, Rongwei Guan, et al.. (2017). Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial–Mesenchymal Transition. Clinical Cancer Research. 23(18). 5598–5610.
13.
Zhao, Yang, Qingyi Wei, Feng Chen, et al.. (2014). Polymorphisms in MicroRNAs Are Associated with Survival in Non–Small Cell Lung Cancer. Cancer Epidemiology Biomarkers & Prevention. 23(11). 2503–2511.
14.
Su, Li. (2013). Clinic research on blood loss control by tranexamic acid during primary unilateral total knee replacement. The Orthopedic Journal of China.
15.
Li, Zhiming, Hui-Qiang Huang, Zhong-Jun Xia, et al.. (2013). Prognostic Value of Interim and Posttherapy 18F-FDG PET/CT in Patients with Mature T-Cell and Natural Killer Cell Lymphomas. Journal of Nuclear Medicine. 54(4). 507–515.
16.
Chen, Shaojie, Yuehui Yin, Xianbin Lan, et al.. (2012). Paced QRS Duration as a Predictor for Clinical Heart Failure Events During Right Ventricular Apical Pacing in Patients with Idiopathic Complete Atrioventricular Block: Results from an Observational Cohort Study (PREDICT-HF). European Journal of Heart Failure. 15(3). 352–359.
17.
Cheung, Winson Y., Rihong Zhai, Jessica Hopkins, et al.. (2012). Single nucleotide polymorphisms in the matrix metalloproteinase gene family and the frequency and duration of gastroesophageal reflux disease influence the risk of esophageal adenocarcinoma. International Journal of Cancer. 131(11). 2478–2486.
18.
Su, Li. (2011). The effect of different drainage of pancreatic duct after pancreaticojejunostomy. Zhonghua putong waike zazhi.
19.
Liu, Chen-Yu, Michael C. Wu, Feng Chen, et al.. (2010). A Large-scale genetic association study of esophageal adenocarcinoma risk. Carcinogenesis. 31(7). 1259–1263.
20.
Sheu, Chau‐Chyun, Rihong Zhai, Li Su, et al.. (2008). Sex-specific association of epidermal growth factor gene polymorphisms with acute respiratory distress syndrome. European Respiratory Journal. 33(3). 543–550.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Eun Young Kim Breakdown of academic impact, for papers by Stig E. Bojesen Breakdown of academic impact, for papers by Dirk Reinhardt Breakdown of academic impact, for papers by Gang Xu Breakdown of academic impact, for papers by Hongwei Wang Breakdown of academic impact, for papers by Rebecca Troisi Breakdown of academic impact, for papers by Anne Zeleniuch‐Jacquotte Breakdown of academic impact, for papers by Mary J. Emond Breakdown of academic impact, for papers by Lei Wang Breakdown of academic impact, for papers by Bo Zhang